"A Change Is Gonna Come" to Treatment of Lupus Nephritis: A Review

This AJKD review outlines how lupus nephritis care is moving beyond glucocorticoids plus mycophenolate toward earlier multi-target regimens that add B-cell and T-cell directed agents such as belimumab, obinutuzumab, and voclosporin.